Taiwan FDA registration 2fad1e9d3c51c0f3cc3dc479f395edd5

McChi Staphylococcus aureus latex agglutination assay set

TW: 邁克奇金黃色葡萄球菌乳膠凝集測定試劑組

Taiwan·Risk Class 1·MICROGEN BIOPRODUCTS INCORPORATION·Registered Oct 14, 2009 – Oct 14, 2014Cancelled

Registration details

Analysis ID: 2fad1e9d3c51c0f3cc3dc479f395edd5
Customs Code: DHA04400821209

Company information

Manufacturer: MICROGEN BIOPRODUCTS INCORPORATION
Manufacturer Country: United Kingdom
Authorized Representative: GLOWAY CO., LTD.

Product details

Intended Use: Limited to the first level identification range of the "Staphylococcus aureus serum reagent (C.3700)" of the Measures for the Administration of Medical Devices.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3700 金黃色葡萄球菌血清試劑
Import Information: import

Dates and status

Registration Date: Oct 14, 2009
Expiry Date: Oct 14, 2014
Cancellation Date: Apr 25, 2018

Cancellation information

Status: Logged out
Reason: 自行鍵入

About this record

Access comprehensive regulatory information for McChi Staphylococcus aureus latex agglutination assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 2fad1e9d3c51c0f3cc3dc479f395edd5 and manufactured by MICROGEN BIOPRODUCTS INCORPORATION. The authorized representative in Taiwan is GLOWAY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.